1. Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors. (June 2019) Authors: Shah, A.Y.; Kotecha, R.R.; Lemke, E.A.; Chandramohan, A.; Chaim, J.L.; Msaouel, P.; Xiao, L.; Gao, J.; Campbell, M.T.; Zurita, A.J.; Wang, J.; Corn, P.G.; Jonasch, E.; Motzer, R.J.; Sharma, P.; Voss, M.H.; Tannir, N.M. Journal: European journal of cancer Issue: Volume 114(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗